Welcome to LookChem.com Sign In|Join Free
  • or
4-(tert-butoxy)-3,3-diMethyl-4-oxobutanoic acid, also known as 2,2-Dimethylbutanedioic Acid 1-(1,1-Dimethylethyl) Ester, is an organic compound with a unique chemical structure. It is characterized by its ester functional group and its ability to participate in various chemical reactions due to its reactive sites.

660423-00-7

Post Buying Request

660423-00-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

660423-00-7 Usage

Uses

Used in Pharmaceutical Industry:
4-(tert-butoxy)-3,3-diMethyl-4-oxobutanoic acid is used as a synthetic intermediate for the production of various chemical compounds with therapeutic activity. Its versatile chemical structure allows it to be a key component in the synthesis of a wide range of pharmaceuticals, including Betulin derivatives, which have potential applications in the treatment of various diseases.
Used in Chemical Synthesis:
In the field of chemical synthesis, 4-(tert-butoxy)-3,3-diMethyl-4-oxobutanoic acid serves as a valuable building block for creating a diverse array of compounds. Its reactivity and functional groups make it a useful starting material for the development of new molecules with potential applications in various industries, such as pharmaceuticals, agrochemicals, and materials science.
Used in Research and Development:
4-(tert-butoxy)-3,3-diMethyl-4-oxobutanoic acid is also utilized in research and development settings, where it can be employed to study the properties and reactivity of various chemical compounds. Its unique structure and functional groups make it an interesting subject for exploring new reaction pathways and developing innovative synthetic methods.

Check Digit Verification of cas no

The CAS Registry Mumber 660423-00-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,0,4,2 and 3 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 660423-00:
(8*6)+(7*6)+(6*0)+(5*4)+(4*2)+(3*3)+(2*0)+(1*0)=127
127 % 10 = 7
So 660423-00-7 is a valid CAS Registry Number.

660423-00-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(tert-butoxy)-3,3-dimethyl-4-oxobutanoic acid

1.2 Other means of identification

Product number -
Other names 4-tert-butoxy-3,3-dimethyl-4-oxobutanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:660423-00-7 SDS

660423-00-7Downstream Products

660423-00-7Relevant academic research and scientific papers

NOVEL COMPOUNDS FOR CONTROLLING ARTHROPODS

-

Page/Page column 55, (2020/01/31)

The present invention relates to novel halogen-substituted compounds, to processes for their preparation and to their use for controlling animal pests, in particular arthropods and especially insects and arachnids.

CARBONYL DERIVATIVES OF BETULIN

-

Paragraph 00105, (2013/03/26)

Disclosed are a compound characterized by the following formula I or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising said compound or a pharmaceutically acceptable salt thereof, wherein R3, L, and A are as described in the application. Said compounds are useful for the treatment of HIV.

PROPENOATE DERIVATIVES OF BETULIN

-

Paragraph 00114, (2013/07/05)

The present invention relates to a compound characterized by the following Formula I or a pharmaceutically acceptable salt thereof, wherein X, Y, and Z are as described herein. Compounds of the present invention are useful for the treatment of HIV.

DERIVATIVES OF BETULIN

-

Paragraph 00201, (2013/07/05)

The present invention relates to compounds characterized by having a structure according to the following Formula I: (I), or a pharmaceutically acceptable salt thereof. Compounds of the present invention are useful for the treatment or prevention of HIV.

PROPENOATE DERIVATIVES OF BETULIN

-

Paragraph 00115, (2013/07/05)

The present invention relates to a compound characterized by Formula (I); or a pharmaceutically acceptable salt thereof, wherein X, Y, and Z are as described herein. Compounds of the present invention are useful for the treatment of HIV.

NEW COMPOUNDS

-

Page 255-256, (2010/02/06)

The present invention relates to new compounds of formula I, (I) a process for their preparation and new intermediates prepared therein, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 660423-00-7